We're excited to have you on board

To view this email as a web page, go here.

1 Health Care and 2 Earnings Trades Seeing Bullish Options Flow In Monday’s Blitz Daily, we’ll take a look at drug developer Novartis after it was on the receiving end of several positive news stories. Monday saw the bulls take a run at drugmaker Novartis, buying long-dated options in size! The company recently announced the launch of phase three trials of its spinal muscular atrophy drug, Zolgensma, in early August.  The Swiss-based firm also reported promising developments with its Kymriah line of cancer therapeutics. That helped bring buyers back for a massive second dip into the options chain this month.  We’re also seeing lots of interest in two of the biggest names in retail reporting earnings this week, along with some green energy tickers. See for yourself… Click Here for Today’s Top Order Flow! All the best, P.S. The trading day may be over six hours long, but I think that’s total B.S. Once the dust settles by about noon, the trading action is mostly done for the day and so am I — just the way I like it! Trading doesn’t have to be complicated… So why spend the whole day staring at a computer screen? Trade Smarter, Not Harder A New Money Crew Publication   Disclaimer & Disclosures The information in this email is intended for informational purposes only and does not guarantee specific results as there is a high degree of risk involved with trading. Also, our traders are real traders and may have financial interests in the companies discussed. Please see our Terms and Conditions for more information. Manage Your Email Preferences Unsubscribe This email was sent by: WealthPress 7751 Belfort Parkway #120 Jacksonville, FL, 32556, US Update Profile